MC1277A1 - Esters et ethers de cephalosporine - Google Patents

Esters et ethers de cephalosporine

Info

Publication number
MC1277A1
MC1277A1 MC791394A MC1394A MC1277A1 MC 1277 A1 MC1277 A1 MC 1277A1 MC 791394 A MC791394 A MC 791394A MC 1394 A MC1394 A MC 1394A MC 1277 A1 MC1277 A1 MC 1277A1
Authority
MC
Monaco
Prior art keywords
group
salts
ethers
formula
esters
Prior art date
Application number
MC791394A
Other languages
English (en)
French (fr)
Inventor
M Montavon
R Reiner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1277A1 publication Critical patent/MC1277A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC791394A 1978-07-19 1979-07-11 Esters et ethers de cephalosporine MC1277A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH778678 1978-07-19

Publications (1)

Publication Number Publication Date
MC1277A1 true MC1277A1 (fr) 1980-05-23

Family

ID=4330453

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791394A MC1277A1 (fr) 1978-07-19 1979-07-11 Esters et ethers de cephalosporine

Country Status (20)

Country Link
US (1) US4292428A (enExample)
EP (1) EP0008372B1 (enExample)
JP (1) JPS5515492A (enExample)
KR (1) KR830000678B1 (enExample)
AT (1) ATE2331T1 (enExample)
AU (1) AU529233B2 (enExample)
CA (1) CA1151641A (enExample)
DE (1) DE2964607D1 (enExample)
DK (1) DK295279A (enExample)
ES (1) ES8101605A1 (enExample)
FI (1) FI782683A7 (enExample)
GR (1) GR72943B (enExample)
HU (1) HU183012B (enExample)
IL (1) IL57795A (enExample)
MC (1) MC1277A1 (enExample)
NO (1) NO782998L (enExample)
NZ (1) NZ191003A (enExample)
PH (1) PH15899A (enExample)
PT (1) PT69939A (enExample)
ZA (1) ZA793501B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526977A (en) * 1981-10-07 1985-07-02 American Home Products Corporation 2-(3-Amino-5-isoxazolyl)-2-oxyimino-acetic acids
JPS61267585A (ja) * 1985-01-16 1986-11-27 Fujisawa Pharmaceut Co Ltd セフアロスポラン酸誘導体もしくはその薬理学的に許容しうる塩
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091211A (en) * 1974-05-05 1978-05-23 Hoffmann-La Roche Inc. Cephalosporins
CA1100129A (en) * 1974-08-02 1981-04-28 William H.W. Lunn Cephalosporin compounds
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
AU510280B2 (en) * 1976-08-30 1980-06-19 Bristol-Myers Company Antibacterial cephalosporin agents
US4178443A (en) * 1977-06-03 1979-12-11 Hoffmann-La Roche Inc. Derivatives of 7 [-substituted oxyimins acetamido] cephalosporins
GB1599232A (en) * 1977-06-03 1981-09-30 Hoffmann La Roche 7-(2-oximinoacetamido)-cephalosporin derivatives

Also Published As

Publication number Publication date
US4292428A (en) 1981-09-29
NO782998L (no) 1980-01-22
ZA793501B (en) 1980-07-30
NZ191003A (en) 1984-05-31
AU4888079A (en) 1980-01-24
IL57795A0 (en) 1979-11-30
GR72943B (enExample) 1984-01-16
ATE2331T1 (de) 1983-02-15
EP0008372A1 (de) 1980-03-05
FI782683A7 (fi) 1980-01-20
EP0008372B1 (de) 1983-01-26
PT69939A (en) 1979-08-01
ES482574A0 (es) 1980-12-16
IL57795A (en) 1982-09-30
AU529233B2 (en) 1983-06-02
KR830000678B1 (ko) 1983-03-28
PH15899A (en) 1983-04-15
JPS5515492A (en) 1980-02-02
DE2964607D1 (en) 1983-03-03
DK295279A (da) 1980-01-20
ES8101605A1 (es) 1980-12-16
CA1151641A (en) 1983-08-09
HU183012B (en) 1984-04-28

Similar Documents

Publication Publication Date Title
JPS5858354B2 (ja) セフェム誘導体
JPH0313237B2 (enExample)
JPS6237037B2 (enExample)
FR2503712A1 (fr) Composes de la cephalosporine et procede pour leur preparation
EP0088853B1 (fr) Nouveaux dérivés de pyridinium thiométhyl céphalosporines, procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2509312A1 (fr) Nouveaux derives acyles, leur preparation et leurs utilisations therapeutiques
IE56488B1 (en) Crystalline cephem-acid addition salts and process for their preparation
EP0060745A2 (fr) Nouveaux dérivés antibiotiques dérivés des céphalosporines
JPH0246565B2 (enExample)
CH629815A5 (en) Oximes derived from 7-(aminothiazolylacetamido)cephalosporanic acid, process of preparation and pharmaceutical compositions
MC1277A1 (fr) Esters et ethers de cephalosporine
FR2488258A1 (fr) Acide 7-beta-(alpha-syn-methoxyimino-alpha - (2-aminothiazol-4-yl) - acetamino)-3-((1,2,3-thiadiazol-5-ylthio) methyl)-3-cepheme-4-carboxylique et derives alkyliques en c1-c6 de celui-ci, compositions contenant ces composes et leurs applications
EP0080944B1 (fr) Nouveaux dérivés de céphalosporines substitués en position 3 par un groupe hétérocycle thiométhyl, procédé de préparation desdits composés et compositions pharmaceutiques en contenant
EP0044238B1 (fr) Dérivés de céphalosporines sulfoxydes, procédé de préparation et compositions pharmaceutiques en contenant
CA1152061A (fr) Procede de preparation de nouvelles oximes o-substituees derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique
EP0099297B1 (fr) Nouveaux dérivés des céphalosporines, leur procédé de préparation et médicaments antibiotiques contenant lesdits dérivés
MC1195A1 (fr) Derives acyles
KR0174117B1 (ko) 새로운 세팔로스포린 유도체 및 그 제조방법
JPS6259708B2 (enExample)
FR2485540A1 (fr) Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant
JPH0246037B2 (ja) Sefuemujudotai
EP0311521B1 (fr) Dérivés des céphalosphorines à pharmacocinétique améliorée, procédé pour leur préparation, compositions pharmaceutiques les contenant et intermédiaire de synthèse
EP0269512B1 (fr) Dérivés des céphalosporines à pharmacocinétique améliorée, procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2591598A1 (fr) Nouveaux derives d'acide ceph-3-em-4-carboxylique, leur preparation et medicaments les contenant
JPH01258683A (ja) 7―/D(−)アルフア―アミノ アルフア―(p―ヒドロキシフエニル)アセトアミド/―3―(1,2,3―トリアゾル―4(5)―チオメチル―3―セフエム―4―カルボン酸1,2プロピレングリコレートの製造びその製造のための新規中間体

Legal Events

Date Code Title Description
YP Annual fee paid